Preventive Effect Nanoparticles
Moringa Oleifera of Supplementation
During Pregnancy Care on Preeclampsia and Anxiety: Study Serotonin Levels
Dina Indrati Dyah Sulistyowati1*, Mardiyono2
Poltekkes Kemenkes Semarang, Indonesia1,2
Email: dinaindrati@gmail.com, muh,mardiyono@gmail.com
|
KEYWORDS |
ABSTRACT |
|
Nanoparticles
of Moringa Oleifera, Serotonin level,
anxiety blood pressure. pregnant women. |
|
|
DOI: 10.58860/ijsh.v3i7.207 |
|
Corresponding Author: Dina Indrati Dyah Sulistyowati*
Email: dinaindrati@gmail.com
INTRODUCTION
Preeclampsia, a condition that occurs during
pregnancy, involves the mother developing hypertension in the third trimester
Furthermore, hypertension during pregnancy is
influenced by various factors such as age, diet, multiple pregnancies, and
stress
The nursing care management of hypertension during
pregnancy can be addressed through both pharmacological and non-pharmacological
means
This study adopts a genuine experimental approach
using a randomized pretest-posttest control group design. The study focused on
hypertensive pregnant women with blood pressure ≥ 130/90 mmHg who sought
prenatal care at the Puskesmas. The participants included 40 pregnant women
with hypertension.
METHOD
This research utilized a true experimental approach with
a randomized pretest-posttest control group design. The study was conducted at Puskesmas,
where eligible participants were hypertensive pregnant women with blood
pressure ≥ 130/90 mmHg attending prenatal care. A total of 40
participants were enrolled and randomly assigned to either the intervention
group receiving Moringa Oleifera nanoparticles at 500 mg/day or the control
group. The primary objective was to measure serotonin levels in serum samples
from pregnant women with hypertension.
RESULT AND DISCUSSION
The distribution of respondents' characteristics across all groups revealed
that a significant portion of respondents were over 35 years old (30%), with
the majority having a junior high school education (35%) and not being employed
(85%). Based on the aforementioned data, the outcomes of various tests,
including Paired T-tests, conducted between the intervention and control
groups, focused on the variable Serotonin.
Table 1.
Characteristics of respondents by Variables,
inclusion criteria, and intervention groups
|
Indicator |
Nano Moringa |
Control |
Itself |
|
|||||||||||
|
N |
Mean % |
SD |
N |
Mean % |
SD |
|
|
||||||||
|
Age |
10 |
31,20 |
6,18 |
10 |
29,30 |
4,62 |
.174 |
|
|||||||
|
Education |
|
|
|
|
|
|
|
|
|||||||
|
- ES |
1 |
10 |
- |
3 |
30 |
- |
.135 |
|
|||||||
|
- FHS |
5 |
50 |
- |
2 |
20 |
- |
.358 |
|
|||||||
|
- HS |
3 |
30 |
- |
4 |
40 |
- |
.132 |
|
|||||||
|
-
UN |
1 |
10 |
- |
1 |
10 |
- |
.606 |
|
|||||||
|
Work |
|
|
|
|
|
|
|
|
|||||||
|
- Work |
4 |
40 |
- |
0 |
0 |
- |
.241 |
|
|||||||
|
-
Doesn't work |
6 |
60 |
- |
10 |
100 |
- |
.966 |
|
|||||||
|
Anxiety/ Hars Scale |
10 |
23,30 |
7,57 |
10 |
18,60 |
8,37 |
.623 |
|
|||||||
|
Serotonin |
10 |
213,32 |
156,42 |
10 |
200,63 |
177,20 |
.109 |
||||||||
Table 2.
Distribution
of Average Serotonin Levels and HARS Scale Before and After Intervention in Intervention
and Control Groups
|
Variable |
Group |
Mean pre |
Mean post |
Mean differenced |
SD |
P-Value |
|
Serotonin |
Intervention |
106.63 |
128.39 |
21.76 |
15.347 |
0.002 |
|
Control |
200.63 |
127.63 |
73.00 |
228.087 |
0.338 |
|
|
|
|
|
|
|
|
|
|
HARS |
Intervention |
18.90 |
9.50 |
9.40 |
6.75 |
0.002 |
|
|
Control |
18.60 |
18.80 |
-0.20 |
0.422 |
0.168 |
The
intervention analysis results for the group indicated a mean of 106.63
(±128.39), with a standard deviation of 15.347, and a significant p-value of
0.002. Conversely, the analysis of the intervention in the control group before
and after showed a mean of 200.63 (±127.63), with a standard deviation of
228.087, and a non-significant p-value of 0.338.
The paired
t-test was conducted to compare anxiety levels between the intervention and
control groups. Before the intervention, the mean anxiety score in the
intervention group was (18.90±9.50), with a standard deviation of 6.75, and a
significant p-value of 0.002. In contrast, the control group showed a mean
anxiety score of (18.60±18.80), a standard deviation of 0.422, and a
non-significant p-value of 0.168 post-intervention. These findings indicate
that nanoparticle moringa oleiefera effectively increased serotonin levels and
reduced anxiety among pregnant women.
Once the
data was confirmed to follow a normal distribution and exhibit homogeneity, the
One-Way Anova test was conducted. The results indicated a significant
difference in average Anxiety test scores across intervention groups (p =
0.006). Similarly, the Serotonin variable showed a significant average
difference in test scores among intervention groups (p = 0.042).
Changes in Anxiety Levels
(HARS Scale) and Serotonin Levels
The results of anxiety levels (HARS scale) based on the
type of treatment given, in detail, can be seen in the figure below.

Figure 1. HARS scale changes by Group Treatment between
Pre and Post
Figure 1. showed an average change in anxiety levels
(HARS scale) before and after no PEMO was administered showed an average
(106.63±128.39), and the control group experienced an average decrease
(200.63±127.63).

Figure 2. Changes in
Serotonin Levels by Treatment Group between Pre and Post
Figure
2. showed average changes in serotonin
levels before and after Treatment NoPEMO showed an average (106.63±128.39) and
the control group experienced an average decrease (200.63±127.63).
The study analysis
revealed that administering nanoparticles derived from Moringa leaf extract led
to elevated serotonin levels and a corresponding reduction in anxiety levels
Moringa
oleifera, known for its medicinal properties such as antioxidants,
anticonvulsants, anti-inflammatory agents, and neuroprotective effects, has
shown promising results in studies involving Wistar rats
The research findings indicated a
reduction in anxiety levels among pregnant women with hypertension following
administration of nanoparticles containing Moringa leaf extract
Certain studies indicate
that a serotonin imbalance can lead to mood disorders like anxiety, anger, and
depression
According to
the study, there are multiple methods to boost serotonin levels in the body beyond
medication and supplements
CONCLUSION
The study findings revealed a
significant difference (p<0.001) between treatment groups before and after
the intervention. The administration of 500 mg/day of moringa oleifera
nanoparticles significantly decreased anxiety levels and increased serotonin
levels, potentially contributing to the prevention of preeclampsia in
hypertensive pregnant women.
REFERENCES
Adamu, A., Jada, M. S., Saidu,
U., Usha, Y. I., Favour, E. G., & Shuaibu, M. N. (2023). Moringa oleifera
(Lam) Root Extracts Elevate Catecholamine Levels in Experimental Rats:
Potential Role of Ethnopharmacology in Combating Depressive Conditions. Jordan
Journal of Biological Sciences, 16(2).
Akter, K., & Khanum, H.
(2021). Prevalence of pre-eclampsia and factors responsible among third
trimester pregnant women in hospital of Dhaka. Biomedical Journal of
Scientific & Technical Research, 33(4), 26089–26097.
Alizadeh Pahlavani, H. (2024).
Possible role of exercise therapy on depression: Effector neurotransmitters as
key players. Behavioural Brain Research, 459, 114791. Retrieved from
https://doi.org/10.1016/j.bbr.2023.114791
Banala, C., Moreno, S., Cruz,
Y., Boelig, R. C., Saccone, G., Berghella, V., … Roman, A. (2020). Impact of
the ACOG guideline regarding low-dose aspirin for prevention of superimposed
preeclampsia in women with chronic hypertension. American Journal of
Obstetrics and Gynecology, 223(3), 419.e1-419.e16. Retrieved from
https://doi.org/10.1016/j.ajog.2020.03.004
Berczi, I. (2019). The
influence of pituitary-adrenal axis on the immune system. Pituitary
Function and Immunity, 49–132.
Biaggi, A., Conroy, S.,
Pawlby, S., & Pariante, C. M. (2016). Identifying the women at risk of
antenatal anxiety and depression: A systematic review. Journal of Affective
Disorders, 191, 62–77. Retrieved from
https://doi.org/10.1016/j.jad.2015.11.014
de Boer, H. J., &
Cotingting, C. (2014). Medicinal plants for women’s healthcare in southeast
Asia: A meta-analysis of their traditional use, chemical constituents, and
pharmacology. Journal of Ethnopharmacology, 151(2), 747–767. Retrieved
from https://doi.org/10.1016/j.jep.2013.11.030
Fidelis, K. R., Alves, R. R.
de V., Patriota, L. L. de S., Coelho, L. C. B. B., Ferreira, M. R. A., Soares,
L. A. L., … Paiva, P. M. G. (2024). Saline Extract from Moringa oleifera
Leaves Has Antidepressant and Anxiolytic Effects in Mouse Models. Nutraceuticals,
4(1), 65–81.
Gopalakrishnan, L., Doriya,
K., & Kumar, D. S. (2016). Moringa oleifera: A review on nutritive
importance and its medicinal application. Food Science and Human Wellness,
5(2), 49–56. Retrieved from https://doi.org/10.1016/j.fshw.2016.04.001
Hassan, M. A., Xu, T., Tian,
Y., Zhong, Y., Ali, F. A. Z., Yang, X., & Lu, B. (2021). Health benefits
and phenolic compounds of Moringa oleifera leaves: A comprehensive review. Phytomedicine,
93, 153771. Retrieved from https://doi.org/10.1016/j.phymed.2021.153771
Hoyer, J., Wieder, G., Höfler,
M., Krause, L., Wittchen, H.-U., & Martini, J. (2020). Do lifetime anxiety
disorders (anxiety liability) and pregnancy-related anxiety predict
complications during pregnancy and delivery? Early Human Development,
144, 105022. Retrieved from https://doi.org/10.1016/j.earlhumdev.2020.105022
J. Hashim, F., Vichitphan, S.,
Boonsiri, P., & Vichitphan, K. (2021). Neuroprotective assessment of
Moringa oleifera leaves extract against oxidative-stress-induced cytotoxicity
in SHSY5Y neuroblastoma cells. Plants, 10(5), 889.
Liu, Y., Zhao, J., & Guo,
W. (2018). Emotional roles of mono-aminergic neurotransmitters in major
depressive disorder and anxiety disorders. Frontiers in Psychology, 9,
2201.
Parker, G. B., Brotchie, H.,
& Graham, R. K. (2017). Vitamin D and depression. Journal of Affective
Disorders, 208, 56–61. Retrieved from
https://doi.org/10.1016/j.jad.2016.08.082
Prins, J. R., Schoots, M. H.,
Wessels, J. I., Campmans-Kuijpers, M. J. E., Navis, G. J., van Goor, H., …
Gordijn, S. J. (2022). The influence of the dietary exposome on oxidative
stress in pregnancy complications. Molecular Aspects of Medicine, 87,
101098. Retrieved from https://doi.org/10.1016/j.mam.2022.101098
Schefft, C., Kilarski, L. L.,
Bschor, T., & Köhler, S. (2017). Efficacy of adding nutritional
supplements in unipolar depression: A systematic review and meta-analysis. European
Neuropsychopharmacology, 27(11), 1090–1109. Retrieved from
https://doi.org/10.1016/j.euroneuro.2017.07.004
Singh, R. B., Horiuchi, R.,
Wilczynska, A., Suchday, S., Tyagi, G., Magomedova, A., … Juneja, L. R.
(2022). The role of modified Mediterranean neuroprotective diet on emotion,
cognition, and depression. In Functional Foods and Nutraceuticals in
Metabolic and Non-Communicable Diseases (pp. 551–579). Elsevier. Retrieved
from https://doi.org/10.1016/B978-0-12-819815-5.00030-6
Thomson, G., Feeley, C.,
Moran, V. H., Downe, S., & Oladapo, O. T. (2019). Women’s experiences of
pharmacological and non-pharmacological pain relief methods for labour and
childbirth: a qualitative systematic review. Reproductive Health, 16,
1–20.
|
© 2023 by the authors. It was
submitted for possible open-access publication under the terms and conditions
of the Creative Commons Attribution (CC BY SA) license (https://creativecommons.org/licenses/by-sa/4.0/). |